News & Updates
Filter by Specialty:
Group CBT with interoceptive exposure safe, effective for drug-refractory IBS
Group cognitive behavioural therapy (GCBT) with interoceptive exposure (IE) is not only safe and effective but also an efficient treatment option for individuals with drug-refractory irritable bowel syndrome (IBS), according to a Japan study.
Group CBT with interoceptive exposure safe, effective for drug-refractory IBS
18 Apr 2022
Androgen deprivation therapy for prostate cancer ups dementia risk
Adult men with prostate cancer who have increasing exposure to androgen deprivation therapy (ADT) are at greater risk of dementia, according to a US study.
Androgen deprivation therapy for prostate cancer ups dementia risk
18 Apr 2022
CYP39A1 G204E variant ups risk of glaucoma, blindness in patients with exfoliation syndrome
Patients with exfoliating syndrome (XFS) who carry the CYP39A1 G204E mutation are at significantly higher risk of blindness, have higher occurrence of exfoliation glaucoma (XFG), and display more severe glaucoma than those with XFS without any CYP39A1 mutation, reveals a study.
CYP39A1 G204E variant ups risk of glaucoma, blindness in patients with exfoliation syndrome
18 Apr 2022
Early molnupiravir use benefits unvaccinated COVID-19 outpatients
Early administration (ie, within 5 days after symptom onset) of the oral, small-molecule antiviral prodrug molnupiravir slashed the risk of hospitalization or death in at-risk, unvaccinated, nonhospitalized adults with mild-to-moderate COVID-19, findings from the phase III component of the phase II/III MOVe-OUT trial have shown.
Early molnupiravir use benefits unvaccinated COVID-19 outpatients
18 Apr 2022
Vitamin E supplementation improves metabolic, hormonal profile in women with PCOS
Regimens containing vitamin E supplements might help improve blood lipid profile and glucose control in women with polycystic ovary syndrome (PCOS), reports a recent meta-analysis.
